Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits.
Avik ChoudhuriEirini TrompoukiBrian J AbrahamLeandro M ColliKian Hong KockWilliam MallardMin-Lee YangDivya S VinjamurAlireza GhamariAudrey SporrijKaren HoiBarbara HummelSonja BoatmanVictoria ChanSierra TsengSatish K NandakumarSong YangAsher LichtigMichael SuperdockSeraj N GrimesTeresa V BowmanYi ZhouShinichiro TakahashiRoby JoehanesAlan B CantorDaniel E BauerSanthi K GaneshJohn RinnPaul S AlbertMartha L BulykStephen J ChanockRichard A YoungLeonard I ZonPublished in: Nature genetics (2020)
Genome-wide association studies identify genomic variants associated with human traits and diseases. Most trait-associated variants are located within cell-type-specific enhancers, but the molecular mechanisms governing phenotypic variation are less well understood. Here, we show that many enhancer variants associated with red blood cell (RBC) traits map to enhancers that are co-bound by lineage-specific master transcription factors (MTFs) and signaling transcription factors (STFs) responsive to extracellular signals. The majority of enhancer variants reside on STF and not MTF motifs, perturbing DNA binding by various STFs (BMP/TGF-β-directed SMADs or WNT-induced TCFs) and affecting target gene expression. Analyses of engineered human blood cells and expression quantitative trait loci verify that disrupted STF binding leads to altered gene expression. Our results propose that the majority of the RBC-trait-associated variants that reside on transcription-factor-binding sequences fall in STF target sequences, suggesting that the phenotypic variation of RBC traits could stem from altered responsiveness to extracellular stimuli.
Keyphrases
- transcription factor
- red blood cell
- dna binding
- copy number
- genome wide
- gene expression
- dna methylation
- endothelial cells
- genome wide association
- induced apoptosis
- genome wide identification
- stem cells
- single cell
- mass spectrometry
- high glucose
- signaling pathway
- induced pluripotent stem cells
- oxidative stress
- epithelial mesenchymal transition
- bone marrow